MoonLake Immunotherapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $101 |
Gross Profit | -745 | -742 | -378 | 50 |
EBITDA | -66,636 | -53,177 | -40,010 | -48,279 |
EBIT | -67,381 | -53,919 | -40,388 | -49,580 |
Net Income | -69,729 | -55,220 | -39,944 | -45,604 |
Net Change In Cash | 0 | 0 | 0 | 101 |
Free Cash Flow | -44,543 | -54,530 | -38,175 | -48,649 |
Cash | 350,736 | 306,681 | 271,566 | 180,426 |
Basic Shares | 63,369 | 63,282 | 63,233 | 63,069 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -1,384 | -13 | -12 |
EBITDA | -141,706 | -53,752 | -65,049 |
EBIT | -143,091 | -54,123 | -65,061 |
Net Income | -118,935 | -36,007 | -64,506 |
Net Change In Cash | 0 | 0 | 0 |
Cost of Revenue | 31,458 | ||
Free Cash Flow | -117,106 | -43,062 | -55,909 |
Cash | 180,426 | 451,169 | 39,505 |
Basic Shares | 62,870 | 49,122 | 29,361 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$1.10 |
2025-06-30 | -$0.87 |
2025-03-31 | -$0.63 |
